Circulating tumor

๐‚๐ข๐ซ๐œ๐ฎ๐ฅ๐š๐ญ๐ข๐ง๐  ๐“๐ฎ๐ฆ๐จ๐ซ ๐ƒ๐๐€ (๐œ๐ญ๐ƒ๐๐€) : ๐…๐ฎ๐ญ๐ฎ๐ซ๐ž ๐’๐œ๐จ๐ฉ๐ž

Circulating tumor DNA (ctDNA) is a type of DNA produced by malignant and tumor cells that spread throughout the body. This occurs when a tumor …

Read More

Gynaecological Cancer Drugs Market To Witness An Escalation Based On Remote Monitoring At A CAGR Of 6.2%

The new report by Persistence Market Research (PMR) expects the globalย gynaecological cancer drugs marketย to witness significant growth, registeringย 6.2% CAGRย during the forecast period. The global gynaecological …

Read More

Triple Negative Breast Cancer Treatment Market is stipulated to witness a CAGR of 5% by the year 2030

Significant rise in awareness about preventative therapies is anticipated to drive the triple-negative breast cancer treatment market during the forecast period. According to WHO, the …

Read More

Digitized Diagnostic Techniques To Drive The Bile Duct Cancer Treatment Market At A CAGR Of 8%

Theย bile duct cancer treatment marketย is expected to grow by leaps and bounds in the forecast period. Nanotechnologyโ€™s medical application is on the anvil. As such, …

Read More

Triple Negative Breast Cancer Treatment Market to exhibit a CAGR of around 5% over the forecast period (2022-2030)

Theย Triple-Negative Breast Cancer Treatment Marketย is expected to witness an escalation going forward. With health apps, biosensors, AI, VR, telehealth, robots, cloud computing, predictive analysis, and …

Read More